Market Leads & Opportunities

United Kingdom-Edinburgh: Trastuzumab powder for reconstitution for intravenous infusion (IV) Vials – Framework Lead

Source: Tracker Intelligence

The current contract for Trastuzumab powder for reconstitution for intravenous infusion (IV) Vials – Framework Lead is projected to end on 28-MAR-20 and may be available for retender. Supply of Trastuzumab powder for reconstitution for intravenous infusion to health boards across NHS Scotland. The procurement will include 150 mg and 440 mg vials.
Full product details and volumes are included in the ITT.